AJR ARRS: Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sevick, R. J.
Right arrow Articles by Lempert, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sevick, R. J.
Right arrow Articles by Lempert, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 159, 171-175, Copyright © 1992 by American Roentgen Ray Society


ARTICLES

Evolution of white matter lesions in neurofibromatosis type 1: MR findings

RJ Sevick, AJ Barkovich, MS Edwards, T Koch, B Berg and T Lempert
Department of Radiology, University of California, San Francisco 94143.

To characterize further the evolution of white matter lesions in neurofibromatosis type 1, we reviewed 68 MR images in 43 patients (age, 1-31 years), including 25 follow-up studies (mean interval, 27 months). Lesion number, location, morphology, signal characteristics, and contrast enhancement were assessed. Lesion characteristics and changes thereof were correlated with the patients' ages. Thirty-four patients (79%) had white matter lesions. These lesions were hyperintense on T2- weighted images, were isointense on T1-weighted images, and showed no mass effect or contrast enhancement in 31 patients; in three patients, T1-prolongation was observed (one with significant mass effect). None of the lesions evolved into a glioma. The most common locations were the cerebellum (49%), brainstem (22%), and internal capsule (19%). Nineteen patients had white matter lesions and follow-up studies. Lesions decreased in size or number in seven patients (average age, 13 years), showed no change in three (average age, 12 years), increased in size or number in four (average age, 5 years), and showed a mixed pattern (increased/decreased size/number) in four (average age, 7 years). White matter lesions in neurofibromatosis type 1 frequently increase in size or number early in childhood; this did not indicate neoplasia in our study. The lesions tend to resolve with increasing age. Lesion progression in a child more than 10 years old warrants close follow-up to rule out a neoplasm.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S. L Hyman, D. S Gill, E. A. Shores, A. Steinberg, and K. N North
T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning
J. Neurol. Neurosurg. Psychiatry, October 1, 2007; 78(10): 1088 - 1091.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
S.L. Zamboni, T. Loenneker, E. Boltshauser, E. Martin, and K.A. Il'yasov
Contribution of Diffusion Tensor MR Imaging in Detecting Cerebral Microstructural Changes in Adults with Neurofibromatosis Type 1
AJNR Am. J. Neuroradiol., April 1, 2007; 28(4): 773 - 776.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. Feldmann, J. Denecke, M. Grenzebach, G. Schuierer, and J. Weglage
Neurofibromatosis type 1: Motor and cognitive function and T2-weighted MRI hyperintensities
Neurology, December 23, 2003; 61(12): 1725 - 1728.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S.L. Hyman, D.S. Gill, E.A. Shores, A. Steinberg, P. Joy, S.V. Gibikote, and K.N. North
Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1
Neurology, April 8, 2003; 60(7): 1139 - 1145.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
L.E. Cutting, K.L. Cooper, C.W. Koth, S.H. Mostofsky, W.R. Kates, M.B. Denckla, and W.E. Kaufmann
Megalencephaly in NF1: Predominantly white matter contribution and mitigation by ADHD
Neurology, November 12, 2002; 59(9): 1388 - 1394.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
K. North, S. Hyman, and B. Barton
Review Article : Cognitive Deficits in Neurofibromatosis 1
J Child Neurol, August 1, 2002; 17(8): 605 - 612.
[Abstract] [PDF]


Home page
J Child NeurolHome page
M. Di Capua, M. L. Lispi, A. Giannotti, D. Longo, and G. Fariello
Neurofibromatosis Type 1 Presenting With Hand Dystonia
J Child Neurol, August 1, 2001; 16(8): 606 - 608.
[Abstract] [PDF]


Home page
Am. J. Neuroradiol.Home page
R. G. Steen, J. S. Taylor, J. W. Langston, J. O. Glass, V. R. Brewer, W. E. Reddick, R. Mages, and E. K. Pivnick
Prospective Evaluation of the Brain in Asymptomatic Children with Neurofibromatosis Type 1: Relationship of Macrocephaly to T1 Relaxation Changes and Structural Brain Abnormalities
AJNR Am. J. Neuroradiol., May 1, 2001; 22(5): 810 - 817.
[Abstract] [Full Text]


Home page
RadiologyHome page
J. D. Eastwood, D. J. Fiorella, J. F. MacFall, D. M. Delong, J. M. Provenzale, and R. S. Greenwood
Increased Brain Apparent Diffusion Coefficient in Children with Neurofibromatosis Type 1
Radiology, May 1, 2001; 219(2): 354 - 358.
[Abstract] [Full Text]


Home page
Arch OphthalmolHome page
C. F. Parsa, C. S. Hoyt, R. L. Lesser, J. M. Weinstein, C. M. Strother, R. Muci-Mendoza, M. Ramella, R. S. Manor, W. A. Fletcher, M. X. Repka, et al.
Spontaneous Regression of Optic Gliomas: Thirteen Cases Documented by Serial Neuroimaging
Arch Ophthalmol, April 1, 2001; 119(4): 516 - 529.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
E. C. Dubovsky, T. N. Booth, G. Vezina, C. A. Samango-Sprouse, K. M. Palmer, and C. O. Brasseux
MR Imaging of the Corpus Callosum in Pediatric Patients with Neurofibromatosis Type 1
AJNR Am. J. Neuroradiol., January 1, 2001; 22(1): 190 - 195.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. G. Curless, J. M. Friedman, and J. Szudek
Use of ""unidentified bright objects"" on MRI for diagnosis of neurofibromatosis 1 in children
Neurology, October 10, 2000; 55(7): 1067 - 1068.
[Full Text] [PDF]


Home page
NeurologyHome page
K. DeBella, K. Poskitt, J. Szudek, and J. M. Friedman
Use of ""unidentified bright objects"" on MRI for diagnosis of neurofibromatosis 1 in children
Neurology, April 25, 2000; 54(8): 1646 - 1651.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
B. D. Moore III, J. M. Slopis, E. F. Jackson, A. E. De Winter, and N. E. Leeds
Brain volume in children with neurofibromatosis type 1: Relation to neuropsychological status
Neurology, February 22, 2000; 54(4): 914 - 920.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
P. D. Griffiths, F. PhD, S. Blaser, W. Mukonoweshuro, D. Armstrong, G. Milo-Manson, and S. Cheung
Neurofibromatosis Bright Objects in Children With Neurofibromatosis Type 1: A Proliferative Potential?
Pediatrics, October 1, 1999; 104(4): 49e - 49.
[Abstract] [Full Text]


Home page
J Child NeurolHome page
G. Perilongo, P. Moras, C. Carollo, A. Battistella, M. Clementi, A. Laverda, and A. Murgia
Spontaneous Partial Regression of Low-Grade Glioma in Children With Neurofibromatosis-1: A Real Possibility
J Child Neurol, June 1, 1999; 14(6): 352 - 356.
[Abstract] [PDF]


Home page
J Child NeurolHome page
A. M. Kaplan, K. Chen, M. A. Lawson, D. L. Wodrich, C. T. Bonstelle, and E. M. Reiman
Positron Emission Tomography in Children With Neurofibromatosis-1
J Child Neurol, November 1, 1997; 12(8): 499 - 506.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Roentgen Ray Society.